Research & Development



  兩名青年對我拳打腳踢,我緊閉嘴,不出聲。他們打累了,大概覺得我挺難對付,便轉向旁邊被捆坐在椅子上的藍波。   我打開酒瓶,遞給寧嘉。寧嘉接過,仰頭喝了兩大口,吞下止痛片和抗生素,然後轉過身,趴在床上。伊人在线大香蕉网4久草   我听從她的建議,不停把自己弄上半空,又摔下來,鐵管發出嘎吱的聲響,搖搖欲墜。我的手腕劇痛難忍,快被勒斷,胳膊肘也幾乎要脫臼。我又蕩起秋千,前後用力,終于,喀嚓一聲,鐵管從牆壁松脫傾倒,我重重摔在地面。大香蕉网伊人在线   九   在楊少卿房間內留下一串串腳印,在他耳邊呼喚他,將他“引”到那間停著他棺材的房間內,一人分飾兩角,同他說著一些在他活著時她便想親口對他說的愛和恨。色天使论坛最新地址

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo